Log In
Print
BCIQ
Print
Print this Print this
 

POL6326

  Manage Alerts
Collapse Summary General Information
Company Polyphor Ltd.
DescriptionCXC chemokine receptor 4 (CXCR4) inhibitor
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationStem cell transplant
Indication DetailsHematopoietic stem cell transplant (HSCT)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today